TNFSF10 and urinary bladder carcinoma: Evodiamine at 1 μM decreased the cell viability of 253J and T24 cells by 25.80% and 22.10% respectively, but the combination of evodiamine and TRAIL exhibited much greater potency than either agent alone in decreasing the cell viability of these two bladder cancer cells.